![Xun Dong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xun Dong
Directeur/Membre du Conseil chez SINOMAB BIOSCIENCE LIMITED
Postes actifs de Xun Dong
Sociétés | Poste | Début | Fin |
---|---|---|---|
SINOMAB BIOSCIENCE LIMITED | Directeur/Membre du Conseil | 23/12/2019 | - |
Yunnan Institute of Materia Medica
![]() Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Xun Dong
Anciens postes connus de Xun Dong
Sociétés | Poste | Début | Fin |
---|---|---|---|
YUNNAN BAIYAO GROUP CO.,LTD | Sales & Marketing | - | - |
Formation de Xun Dong
Southampton Business School | Undergraduate Degree |
University of Warwick | Graduate Degree |
Statistiques
Internationale
Royaume-Uni | 3 |
Chine | 3 |
Hong Kong | 2 |
Opérationnelle
Director/Board Member | 2 |
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
SINOMAB BIOSCIENCE LIMITED | Health Technology |
YUNNAN BAIYAO GROUP CO.,LTD | Health Technology |
Entreprise privées | 1 |
---|---|
Yunnan Institute of Materia Medica
![]() Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Health Technology |